Candriam SCA’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $129M | Sell |
510,174
-288,641
| -36% | -$67.3M | 0.58% | 33 |
|
|
2026
Q1 | $195M | Buy |
798,815
+49,216
| +7% | +$11.5M | 1.01% | 13 |
|
|
2025
Q4 | $155M | Buy |
749,599
+113,575
| +18% | +$22.5M | 0.77% | 23 |
|
|
2025
Q3 | $118M | Buy |
636,024
+340,354
| +115% | +$58.3M | 0.62% | 31 |
|
|
2025
Q2 | $45.2M | Sell |
295,670
-3,444
| -1% | -$529K | 0.26% | 89 |
|
|
2025
Q1 | $49.6M | Buy |
299,114
+22,060
| +8% | +$3.45M | 0.31% | 83 |
|
|
2024
Q4 | $40.1M | Buy |
277,054
+11,902
| +4% | +$1.84M | 0.23% | 88 |
|
|
2024
Q3 | $43M | Sell |
265,152
-15,083
| -5% | -$2.4M | 0.25% | 84 |
|
|
2024
Q2 | $41M | Buy |
280,235
+6,736
| +2% | +$1M | 0.25% | 89 |
|
|
2024
Q1 | $43.3M | Sell |
273,499
-33,731
| -11% | -$5.37M | 0.28% | 81 |
|
|
2023
Q4 | $48.2M | Sell |
307,230
-179,678
| -37% | -$27.6M | 0.33% | 73 |
|
|
2023
Q3 | $75.8M | Sell |
486,908
-332,735
| -41% | -$54.9M | 0.54% | 34 |
|
|
2023
Q2 | $136M | Sell |
819,643
-43,858
| -5% | -$7.08M | 0.98% | 16 |
|
|
2023
Q1 | $123M | Buy |
863,501
+172,445
| +25% | +$27.8M | 0.85% | 18 |
|
|
2022
Q4 | $122M | Buy |
691,056
+195,274
| +39% | +$33.7M | 0.82% | 18 |
|
|
2022
Q3 | $81M | Sell |
495,782
-145,989
| -23% | -$24.7M | 0.57% | 30 |
|
|
2022
Q2 | $114M | Sell |
641,771
-229,897
| -26% | -$41M | 0.94% | 16 |
|
|
2022
Q1 | $154M | Sell |
871,668
-3,638
| -0.4% | -$619K | 1.05% | 16 |
|
|
2021
Q4 | $150M | Sell |
875,306
-107,120
| -11% | -$17.5M | 0.96% | 15 |
|
|
2021
Q3 | $159M | Buy |
982,426
+337,232
| +52% | +$57.5M | 1.08% | 11 |
|
|
2021
Q2 | $106M | Buy |
645,194
+41,249
| +7% | +$6.83M | 0.73% | 24 |
|
|
2021
Q1 | $91.3M | Sell |
603,945
-7
| -0% | -$1.13K | 0.76% | 23 |
|
|
2020
Q4 | $95M | Buy |
603,952
+187,791
| +45% | +$27.7M | 0.75% | 23 |
|
|
2020
Q3 | $62M | Buy |
416,161
+5,780
| +1% | +$855K | 0.58% | 34 |
|
|
2020
Q2 | $57.7M | Buy |
410,381
+14,735
| +4% | +$2.15M | 0.61% | 31 |
|
|
2020
Q1 | $56.4M | Buy |
395,646
+40
| +0% | +$5.67K | 0.63% | 28 |
|
|
2019
Q4 | $57.7M | Sell |
395,606
-20,887
| -5% | -$2.83M | 0.62% | 28 |
|
|
2019
Q3 | $53.9M | Buy |
416,493
+3,961
| +1% | +$522K | 0.71% | 24 |
|
|
2019
Q2 | $62.2M | Buy |
412,532
+13,912
| +3% | +$1.93M | 0.78% | 21 |
|
|
2019
Q1 | $61M | Buy |
398,620
+21,096
| +6% | +$2.83M | 0.78% | 23 |
|
|
2018
Q4 | $48.7M | Sell |
377,524
-47,205
| -11% | -$6.58M | 0.75% | 24 |
|
|
2018
Q3 | $58.7M | Buy |
424,729
+236
| +0.1% | +$31.4K | 0.78% | 22 |
|
|
2018
Q2 | $51.5M | Buy |
424,493
+5,223
| +1% | +$652K | 0.82% | 19 |
|
|
2018
Q1 | $53.7M | Buy |
419,270
+84,393
| +25% | +$11.4M | 0.92% | 14 |
|
|
2017
Q4 | $46.8M | Sell |
334,877
-199,812
| -37% | -$27.8M | 0.81% | 15 |
|
|
2017
Q3 | $69.5M | Buy |
534,689
+26,071
| +5% | +$3.46M | 1.21% | 10 |
|
|
2017
Q2 | $67.3M | Sell |
508,618
-10,186
| -2% | -$1.3M | 1.26% | 9 |
|
|
2017
Q1 | $64.6M | Sell |
518,804
-444,987
| -46% | -$53.2M | 1.25% | 11 |
|
|
2016
Q4 | $111M | Buy |
963,791
+210,925
| +28% | +$24.4M | 2.55% | 2 |
|
|
2016
Q3 | $88.9M | Buy |
752,866
+23,922
| +3% | +$2.9M | 2.14% | 3 |
|
|
2016
Q2 | $88.4M | Buy |
728,944
+179,216
| +33% | +$20.4M | 2.3% | 2 |
|
|
2016
Q1 | $59.2M | Sell |
549,728
-271,111
| -33% | -$28.1M | 1.48% | 8 |
|
|
2015
Q4 | $84.3M | Sell |
820,839
-207,632
| -20% | -$20.9M | 2.26% | 4 |
|
|
2015
Q3 | $96M | Buy |
1,028,471
+47,086
| +5% | +$4.55M | 2.36% | 3 |
|
|
2015
Q2 | $95.6M | Buy |
981,385
+18,573
| +2% | +$1.86M | 1.99% | 4 |
|
|
2015
Q1 | $96.9M | Buy |
962,812
+420,546
| +78% | +$42.8M | 1.95% | 2 |
|
|
2014
Q4 | $56.7M | Buy |
+542,266
| New | +$57.1M | 1.19% | 8 |
|
Other funds holding JNJ
Candriam SCA's JNJ Position: Q2 2026 in Review
Candriam SCA reduced its Johnson & Johnson (JNJ) stake by 36% in Q2 2026, selling an estimated $67.3M and leaving 510,174 shares worth $129M. The position accounts for 0.58% of the portfolio, ranked #33.
Candriam SCA first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $195M in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Candriam SCA held 510,174 shares of Johnson & Johnson worth $129M as of Q2 2026.
- Candriam SCA sold 288,641 Johnson & Johnson shares in Q2 2026, an estimated $67.3M.
- Johnson & Johnson made up 0.58% of Candriam SCA's portfolio in Q2 2026, its #33 holding.
- Candriam SCA first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Johnson & Johnson position peaked at $195M in Q1 2026.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.